At Daiichi Sankyo, we attach significant importance to working with academic institutions and bioventure companies to discover new therapeutics in the place where hypotheses are brought and tested in order to expand possibilities for scientific innovation breakthrough. We build sustainable relationships with partner institutions and companies through open and fair alliance management and trust based on mutual respect as the foundation for effective collaborations. Our goal is to jointly create new value for patients by maximizing each other’s expertise and strengths.
Our Approach to Collaboration
We collaborate globally through variety of programs and are open to new collaborative research proposals at any time.
- Open and
TaNeDS Global Program
For a collaborative drug discovery initiative for universities and research institutes in Europe and the East Coast of the United States, we launched Take a New Challenge for Drug Discovery (TaNeDS) Global program.
The TaNeDS program was started in Japan in 2011 to help discover new lines of research through open innovation. From 2013, it expanded outside of Japan, opening up to worldwide researchers. The aim of the program will continue to be increasing collaborative opportunities between Daiichi Sankyo and researchers outside of Japan.
Recent Major Research Collaborations
Visit here to see a list of our past research collaborations.
Our Areas of Interest
We are seeking collaborations in these areas. (Last updated July, 2022)
If you would like to submit a licensing proposal, see our “Partnering” page for more information.